• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

488.79 +4.76 (+0.98%)
Streaming Delayed Price Updated: 10:44 AM EDT, Aug 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
75 76 Next >
News headline image
The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024 ↗
July 09, 2024
Finding undervalued gene editing stocks is easy, but having the patience to stick with them is the challenge. 
Via InvestorPlace
News headline image
Healthcare Stocks Continue To Lag The Market-Can Anything Help ? ↗
July 08, 2024
Healthcare stocks continue to lag the market up about 6% YTD, helped by Large Cap Biopharma but hurt by United Health. 
Via Talk Markets
News headline image
3 No-Brainer Stocks to Buy in July ↗
July 08, 2024
Investors shouldn't have to think too hard about these great stocks. 
Via The Motley Fool
News headline image
3 Pharma Stocks Already Ushering in the Next Biotech Boom ↗
July 08, 2024
So long as diseases afflict the human condition, there will likely always be a need for pharma stocks. Here are three to consider. 
Via InvestorPlace
News headline image
Prediction: This Will Be Vertex Pharmaceuticals' New Billion-Dollar Growth Driver (and It's Coming Soon). ↗
July 06, 2024
Vertex shares have advanced by triple digits over the past few years. 
Via The Motley Fool
News headline image
Why the quality investor may take a look at NASDAQ:VRTX. ↗
July 03, 2024
Examining the Quality Attributes of NASDAQ:VRTX. 
Via Chartmill
News headline image
$1000 Invested In This Stock 15 Years Ago Would Be Worth $14,000 Today ↗
July 01, 2024
 
Via Benzinga
News headline image
Peering Into Vertex Pharmaceuticals's Recent Short Interest ↗
June 26, 2024
 
Via Benzinga
News headline image
The 3 Best Biotech Stocks to Buy in July 2024 ↗
July 05, 2024
For investors looking for promising biotech investments should explore the best biotech stocks to watch in July 2024. 
Via InvestorPlace
News headline image
1 Stock That Increased 10,000% in 33 Years to Buy and Hold Forever ↗
July 05, 2024
It's not too late to get in on the act. 
Via The Motley Fool
News headline image
Did Vertex Pharmaceuticals Just Invent the Next Ozempic? ↗
July 05, 2024
Vertex Pharmaceuticals likely has a breakthrough medicine on its hands. 
Via The Motley Fool
News headline image
Forget Eli Lilly: 3 Biotech Stocks to Buy Instead ↗
July 04, 2024
Eli Lilly is a good stock to buy, but these should be even better. 
Via The Motley Fool
News headline image
3 Top-Rated Gene Editing Stocks Actually Making Money ↗
July 03, 2024
Profitable gene editing stocks make increasingly compelling investments as therapies commercialize this year and beyond. 
Via InvestorPlace
News headline image
Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
July 02, 2024
The biotech sector (IBB) is trading just 3% away from its 52-week high and a significant resistance level, suggesting a potential breakout. 
Via MarketBeat
Topics ETFs
News headline image
Investors seeking growth at a reasonable cost should explore NASDAQ:VRTX. ↗
June 20, 2024
NASDAQ:VRTX is not too expensive for the growth it is showing. 
Via Chartmill
News headline image
Vertex Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-In-Class Triple Combination Treatment for Cystic Fibrosis
July 02, 2024
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
3 Under-the-Radar Biotech Stocks With Blockbuster Potential ↗
July 02, 2024
Are you looking to boost your portfolio with the best under-the-radar biotech stocks? Here are the top three. 
Via InvestorPlace
News headline image
Vertex to Announce Second Quarter 2024 Financial Results on August 1
July 01, 2024
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
3 Breakout Biotech Stocks on Track to Double by 2032 ↗
July 01, 2024
The tech sector has been at the forefront of the market rally in 2024. Consider these breakout biotech stocks as a great way to diversify. 
Via InvestorPlace
News headline image
Bull Market Buys: 2 Growth Stocks to Own for the Long Run ↗
July 01, 2024
The latest bull market has plenty of intriguing buying opportunities. 
Via The Motley Fool
News headline image
2 Superior Growth Stocks to Buy if You Have $1,000 Right Now ↗
June 28, 2024
Growth stocks with wide moats and strong financials can compound investor returns with time. 
Via The Motley Fool
News headline image
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030 ↗
June 28, 2024
These healthcare stocks have clear paths to growth over the next few years. 
Via The Motley Fool
News headline image
2 Healthcare Stocks That Are Screaming Buys in June ↗
June 28, 2024
These top healthcare stocks are no-brainer buys in 2024 and beyond. 
Via The Motley Fool
News headline image
You’ve Been Warned! 3 Biotech Stocks to Buy Now or Regret Forever. ↗
June 27, 2024
Invest in the top biotech stocks to buy, as the sector pivots from pandemic-driven vaccine sales to solutions for chronic conditions. 
Via InvestorPlace
News headline image
This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗
June 27, 2024
 
Via Benzinga
News headline image
Is CRISPR Therapeutics Stock a Buy? One Analyst Thinks the Biotech Is "Very Undervalued." ↗
June 27, 2024
The biotech's shares have traded sideways for over a year, but better days could be on the near-term horizon. 
Via The Motley Fool
News headline image
3 Biotech Stocks That Could Make Your Grandchildren Rich ↗
June 27, 2024
These biotech stocks are poised to generate significant returns to investors due to their high growth potential. 
Via InvestorPlace
News headline image
Everyone's Talking About Vertex Pharmaceuticals. Is It Time to Buy? ↗
June 25, 2024
It looks like Vertex's experimental new therapy could become a functional cure for lots of people with diabetes. 
Via The Motley Fool
News headline image
Vertex Announces Positive Results From Ongoing Phase 1/2 Study of VX-880 for the Treatment of Type 1 Diabetes Presented at the American Diabetes Association 84th Scientific Sessions
June 21, 2024
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
Forget Eli Lilly, Buy This Magnificent Biotech Stock Instead ↗
June 21, 2024
Lilly is a good pick...but this one is better. 
Via The Motley Fool
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
75 76 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap